Regular surveillance for Li-fraumeni syndrome: Advice, adherence and perceived benefits

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 647-654

  Lammens, C R M ^a   Bleiker, E M A ^a   Aaronson, N K ^a   Wagner, A ^b   Sijmons, R H ^c   Ausems, M G E M ^d   Vriends, A H J T ^e   Ruijs, M W G ^a,f   Van Os, T A M ^g   Spruijt, L ^h   Gomez Garcia E B ⁱ   Cats, A ^a   Nagtegaal, T ^a   Verhoef, S ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Compliance; Li Fraumeni syndrome (LFS); Psychological barriers and benefits; Surveillance

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CONSULTATION; CONTROLLED STUDY; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENES, P53; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL;

EID: 78650217249     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9368-z     Document Type: Article

References (27)

1. D Malkin FP Li LC Strong, et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1233 1238 1:CAS:528:DyaK3MXjslSisw%3D%3D 10.1126/science.1978757 1978757 (Pubitemid 120031831)
2. A Chompret L Brugieres M Ronsin, et al. 2000 P53 germline mutations in childhood cancers and cancer risk for carrier individuals Br J Cancer 82 1932 1937 10.1054/bjoc.2000.1167 10864200 (Pubitemid 30326453)
3. SJ Hwang G Lozano CI Amos, et al. 2003 Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk Am J Hum Genet 72 975 983 1:CAS:528:DC%2BD3sXivFWgurs%3D 10.1086/374567 12610779 (Pubitemid 36403315)
4. M Hisada JE Garber CY Fung, et al. 1998 Multiple primary cancers in families with Li-Fraumeni syndrome J Natl Cancer Inst 90 606 611 1:STN:280:DyaK1c3htlWjtA%3D%3D 10.1093/jnci/90.8.606 9554443 (Pubitemid 28204804)
5. JM Varley DG EVans JM Birch 1997 Li-Fraumeni syndrome-a molecular and clinical review Br J Cancer 76 1 14 1:CAS:528:DyaK2sXkslaiu7Y%3D 9218725 (Pubitemid 27250068)
6. HJ Jarvinen JP Mecklin P Sistonen 1995 Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer Gastroenterology 108 1405 1411 1:STN:280:DyaK2M3ks12ksQ%3D%3D 10.1016/0016-5085(95)90688-6 7729632
7. SA Narod K Offit 2005 Prevention and management of hereditary breast cancer J Clin Oncol 23 1656 1663 10.1200/JCO.2005.10.035 15755973 (Pubitemid 46211420)
8. L Renkonen-Sinisalo M Aarnio JP Mecklin, et al. 2000 Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer Cancer Detect Prev 24 137 142 1:STN:280: DC%2BD3M%2Fhtlylug%3D%3D 10917133 (Pubitemid 30427699)
9. National Comprehensive Cancer Network 1999 NCCN practice guidelines: genetics/familial high risk cancer Oncology 13 161 186
10. Schneider KA (2004) Li Fraumeni syndrome. Gene Rev ( www.genetests.org )
11. S Masciari AD Van den Abbeele LR Diller, et al. 2008 F18- fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome JAMA 299 1315 1319 1:CAS:528:DC%2BD1cXjsV2gtbo%3D 10.1001/jama.299.11.1315 18349092 (Pubitemid 351439077)
12. RE Mitchel JS Jackson SM Carlisle 2004 Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice Radiat Res 162 20 30 1:CAS:528:DC%2BD2cXlslWhtL8%3D 10.1667/RR3190 15222780 (Pubitemid 39044715)
13. JM Varley 2003 Germline TP53 mutations and Li-Fraumeni syndrome Hum Mutat 21 313 320 1:CAS:528:DC%2BD3sXis1yjtLc%3D 10.1002/humu.10185 12619118 (Pubitemid 36292974)
14. Netherlands Foundation for the Detection of Hereditary Tumours, Dutch Society for Clinical Genetics: Hereditary Cancer: diagnostic and preventive guidelines (ed 3) (2005). Leiden, the Netherlands Foundation for the Detection of Hereditary Tumours, Dutch Society for Clinical Genetics, pp 14-16
15. C Lammens S Verhoef N Aaronson, et al. 2010 Genetic testing in Li-Fraumeni Syndrome: Uptake and psychosocial consequences J Clin Oncol 28 3008 3014 10.1200/JCO.2009.27.2112 20479422
16. E Claes L Denayer G Evers-Kiebooms, et al. 2004 Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact Patient Educ Couns 55 265 274 10.1016/j.pec.2003.11.002 15530764 (Pubitemid 39458227)
17. VL Champion 1984 Instrument development for health belief model constructs ANS Adv Nurs Sci 6 73 85 1:STN:280:DyaL2c3gtFOjtQ%3D%3D 6426380
18. KM Kash JC Holland MS Halper, et al. 1992 Psychological distress and surveillance behaviors of women with a family history of breast cancer J Natl Cancer Inst 84 24 30 1:STN:280:DyaK387kvVyntA%3D%3D 10.1093/jnci/84.1.24 1738170
19. JB Madalinska M Van Beurden EM Bleiker, et al. 2007 Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers J Clin Oncol 25 301 307 10.1200/JCO.2006.07. 4922 17235045 (Pubitemid 350003018)
20. D Brom RJ Kleber 1985 De schok verwerkingslijst [Impact of Event Scale] Ned Tijdschr Psychol 40 164 168
21. MJ Horowitz 1986 Stress-response syndromes: a review of posttraumatic and adjustment disorders Hosp Commun Psychiatr 37 241 249 1:STN:280: DyaL287ms1eksw%3D%3D (Pubitemid 16140948)
22. KF Douma NK Aaronson HF Vasen, et al. 2010 Psychological distress and use of psychosocial support in familial adenomatous polyposis Psycho-Oncol 19 289 298 10.1002/pon.1570
23. C Lerman K Kash M Stefanek 1994 Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior Monogr Natl Cancer Inst 16 171 176 7999461
24. Netherlands Foundation for the Detection of Hereditary Tumours (2010) Li-Fraumeni syndrome. Diagnostic and preventive guidelines, Hereditary cancer, pp 16-19
25. National Comprehensive Cancer Network (NCCN) (2010) The NCCN Clinical Practice Guidelines in Oncology™ Li-Fraumeni syndrome (Version 1.2010). NCCN. www.nccn.com
26. C Eng H Hampel A de la Chapelle 2001 Genetic testing for cancer predisposition Annu Rev Med 52 371 400 1:CAS:528:DC%2BD3MXhs1KhsbY%3D 10.1146/annurev.med.52.1.371 11160785 (Pubitemid 32195331)
27. SC EVans G Lozano 1997 The Li-Fraumeni syndrome: an inherited susceptibility to cancer Mol Med Today 3 390 395 1:CAS:528:DyaK2sXmt1Cmtbg%3D 10.1016/S1357-4310(97)01105-2 9302689 (Pubitemid 28127958)